Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03040102
Other study ID # 17-026
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 9, 2017
Est. completion date February 1, 2019

Study information

Verified date August 2022
Source Massachusetts General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research study is to compare two ways to educate patients with cancer and their caregivers about hospice care services


Description:

The purpose of this research study is to compare two ways to educate patients with cancer and their caregivers about hospice care services - a video educational tool or a verbal narrative. The study will assess the effect of these methods on patients' and caregivers' knowledge about hospice care, as well as their perceptions and preferences for this service. Using this research, the investigators hope to find out the best way to help patients and their loved ones better understand hospice care. The educational methods used in this study (the video educational tool or verbal narrative) are meant to serve as an introduction to hospice care. Further details about hospice should be discussed directly with your care team. This study will enroll 150 patients with advanced cancer and up to 150 of their caregivers in this randomized clinical trial. The study will use questionnaires to measure the participant and the caregivers' knowledge of hospice care, as well as your perceptions and preferences for these services. Study assessments will be completed before and after watching the video or hearing the verbal narrative in the hospital.


Recruitment information / eligibility

Status Completed
Enrollment 194
Est. completion date February 1, 2019
Est. primary completion date February 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Patients Eligibility Criteria: - Adult patients (=18 years) with a diagnosis of metastatic solid cancer. - A prognosis of 12 months or less based on the treating oncologist's assessment. - The ability to provide informed consent. - Ability to comprehend and speak English. Caregivers Eligibility Criteria: - Adult caregivers (>18 years) of patients who have agreed to participate in study. - A relative or a friend upon whom the patient relies for help and who will be likely to be present during hospitalization, or willing to participate by phone. - Ability to comprehend and speak English. Exclusion Criteria: Patients Exclusion Criteria: -Significant uncontrolled psychiatric disorder (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (dementia, cognitive impairment), which the treating clinician believes prohibits the ability to participate in study procedures

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Hospice Video Educational Tool
it's a 6 minute video regarding hospice care
Standard of Care
Standard of Care practice is used

Locations

Country Name City State
United States Massachusetts general Hospital Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Massachusetts General Hospital Gordon and Betty Moore Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Patient Perception of Hospice Care Questionnaire we will assess perception of hospice using the Hospice Perception Questionnaire immediately after the video intervention or verbal narrative
Other Patient Hospice Utilization We will assess patient hospice utilization and length of stay in hospice 1 year after study completion
Other Caregiver Preference for Hospice Question we will assess caregiver's preference for their loved one using hospice (yes vs. no) immediately after the video intervention or verbal narrative
Other Caregiver Knowledge about Hospice Questionnaire we will assess knowledge about hospice using 10 knowledge questions immediately after the video intervention or verbal narrative
Other Caregiver Perception of Hospice Care Questionnaire we will assess perception of hospice using the Hospice Perception Questionnaire immediately after the video intervention or verbal narrative
Other Caregiver satisfaction with end-of-life care (FAMCARE) We will use 9 items from the FAMCARE to assess caregivers' satisfaction with patient's end of life care 1 year after study completion
Primary Patient Preference for Hospice Question We will ask patients whether they would prefer to receive hospice care at the end of life (yes vs. no) immediately after the video intervention or verbal narrative
Secondary Patient knowledge about hospice Questionnaire we will assess knowledge about hospice using 10 knowledge questions immediately after the video intervention or verbal narrative
See also
  Status Clinical Trial Phase
Completed NCT03181854 - Randomized Controlled Trial of Integrated Early Palliative Care N/A
Completed NCT01197170 - Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance Phase 1
Recruiting NCT05045040 - Empathetic Communication Facilitation Program for Early Initiation of End-of-life Discussions N/A
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03994601 - An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Completed NCT01393990 - A Study of LY2228820 in Participants With Advanced Cancer Phase 1
Completed NCT02857270 - A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer Phase 1
Recruiting NCT03175224 - APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors Phase 2
Active, not recruiting NCT04121676 - Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer Phase 1
Active, not recruiting NCT03177291 - Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC Phase 1
Completed NCT03980041 - Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) Phase 2
Active, not recruiting NCT03674567 - Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab Phase 1/Phase 2
Recruiting NCT04823377 - Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer. N/A
Completed NCT02778126 - A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer Phase 1
Completed NCT02507544 - A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer Phase 1
Completed NCT02529553 - A Study of LY3076226 in Participants With Advanced or Metastatic Cancer Phase 1
Completed NCT02245204 - Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers Phase 1
Completed NCT01583777 - Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced Cancer Phase 1
Terminated NCT01929941 - An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies Phase 1